Member spotlight: Meet RRxCO

Craig Bridgland .png

Meet Craig Bridgland, the Business Director of RRxCOa global innovative life science consultancy firm, a partnership organisation providing quality & audit services, technical training, and search & selection recruitment. In this blog, Craig talks about RRxCO’s passion, services, achievements and what sets the company apart.

Tell us about your company and ambitions.

RRxCo is an innovative life science consultancy firm based in the United Kingdom, as a specialist provider of end-to-end solutions to support Biotechnology start-ups to established Pharmaceutical Manufacturing and Clinical Research Organisations to achieve and maintain regulatory readiness. Our passion for innovation, collaboration, integrity, and an unwavering commitment to delivering high-quality simple solutions has propelled us to work with life-altering organisations.

At RRxCo we want to effect real change in the industry and be a major contributor to our customers' success whether this would be to achieve a site license, build a start-up biotech firm from the ground floor or the consolidation of established business units. We appreciate the challenges that everyone faces however we work with customers in tandem to partner and reach a solution together.

What is your company’s biggest achievement so far?

Our biggest achievement so far is being partnered with some of the most interesting and lifesaving technology/life science companies in the world. It’s a huge achievement for RRxCo with every customer we support as we are not a transactional business and never will be.

What are some of the priorities that you’re currently working on?

A lot of organisations are finding it challenging to secure funding at present so enabling customers to spend the right amount of resources and also on the right solution is number one for us at present. We also appreciate that securing good talent is very difficult along with new factors to take into consideration; flexibility, higher salaries, increase in SME Contractors vs Senior Permanent Talent. We map Technical Operations (QA, QC, CMC, Validation, etc.) skill sets across the market, making identification and engagement of talent extremely simple. This allows us to focus on the customer's message that we are presenting to engage certain talent pools and ensure that every aspect of the company and position is defined, including the EVP is fit for purpose and live data is used to make educated decisions on what direction to go.

Growth & Efficiency – We are not able to help everyone. This is very frustrating to say to customers, we have all the capability and experience at our fingertips however sometimes capacity is a challenge. As a start-up with over 50 years of combined experience, our priority is to grow our business with the right talent whether the previous experience is held, we truly believe attitude and values beat experience every time. We are surrounded by a community of both internal and external support channels to learn, grow, and understand.

What has been the greatest benefit of being a BIA member?

Being welcomed with resources and a community that provides a platform for exposure and the opportunity to understand more about challenges across members and the wider industry is extremely helpful. The platform enables RRxCo to get closer to market trends, current and common issues that everyone faces in the industry.

What excites you about the UK life sciences sector?

The level of innovation that is happening and that can happen. Out of all other industries we are the closest to making all life (human and animal) better. Knowing that we could be helping an organisation to either save a life or make one better is extremely satisfying. Everyone has been on an extreme roller coaster in the last 5 years and something that has grounded me is what we do in life science.

If you could invite any scientist or entrepreneur to dinner, who would it be and why?

Steven Bartlett! What Steven has achieved is incredible, regardless of start or finish, what fascinates me is the journey he went on, literally grinding away like water on a rock face. Whether business, personal growth or just being exactly who he says he is has really grounded me personally and professionally to just do “that extra bit” on each task, each day and with each person – the compounding of massive effort and action really did help me achieve the right direction, not the destination. Speaking just specifically about the “Diary of the CEO” podcast I would highly recommend anyone to listen, regardless of what you are trying to do, there is a massive information bank if you’re willing to take the time.


More news and updates

Dispatches from the party conferences – Liberal Democrats

In this first instalment of dispatches by the BIA team attending the conferences, Dr. Martin Turner, BIA's Head of Policy and Public Affairs, reports on what he’s heard from the Liberal Democrats.

Women In Biotech Mentoring Programme: Mentee experience – Alex Gajdosova

In this interview, Alex Gajdosova, an Investment Analyst at 4BIO Capital reflects on her inspiring career journey and her decision to participate in the BIA’s Women In Biotech Mentoring Programme as a mentee.

CEO Update - 25 September 2023

The government is introducing legislation to reverse the reinstatement of the 1.5% stamp tax charge on issues and certain transfer of shares to depositary receipts issuers and clearance services – so as, broadly, to preserve the position as before the Retained EU Law (Revocation and Reform) Act was passed.

Women In Biotech Mentoring Programme: mentee experience - Hilary Birrell

In this interview, we delve into the remarkable career journey of Hilary Birrell, a seasoned biochemist with 35 years of experience in clinical trial operations. She shares her motivation for becoming a mentee in the Women In Biotech Mentoring Programme and the invaluable insights gained from her mentor.

CEO Update - 18 September 2023

It was an honour to represent our sector at the first-ever meeting of the UK Biosecurity Leadership Council, chaired by Science Minister George Freeman MP. Looking around the table, it was clear to see that the UK’s strategic advantage in the responsible use of engineering biology is that we have a diverse and world-leading set of capabilities from pioneering science to regulation and thought leadership – and that we are small enough, and networked enough as a nation to get together in a room to set agendas and work plans at pace and scale that can be globally impactful.

Powering regional growth: the Cambridge cluster

Our burgeoning life sciences sector contributes £94 billion to the UK’s economy each year and employs over 280,000 people. But did you know that Cambridge as a region is home to one of the world’s most successful life sciences and biotechnology hubs?

Alzheimer’s disease diagnosis and treatment: Never too early, never too late

September is World Alzheimer’s Month but in the history of diagnosis and treatment of Alzheimer’s disease (AD), 2023 will go down as a landmark year of progress.

CEO Update - 11 September 2023

Last week, the UK scientists celebrated the rejoining Horizon Europe research programme. For research and the flow of talented scientists, it is undoubtedly a good thing that has taken too long to agree. The UK government press release was clear that “Horizon will give UK COMPANIES and research institutions unrivalled opportunities to lead global work to develop new technologies and research projects, in areas from HEALTH to AI”.


More within